Zytanix 5 Tablet contains Metolazone 5mg, a potent thiazide-like diuretic primarily indicated for the management of edema associated with congestive heart failure, chronic kidney disease, and hepatic cirrhosis. Metolazone acts on the distal convoluted tubule of the nephron, inhibiting sodium and chloride reabsorption, thereby promoting increased excretion of sodium, chloride, and water. This mechanism effectively reduces fluid overload, alleviating symptoms such as swelling and breathlessness. Zytanix 5 is also utilized in the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents, to achieve optimal blood pressure control. The pharmacokinetic profile of Metolazone allows for a prolonged diuretic effect, making it suitable for once-daily dosing. Caution is advised in patients with electrolyte imbalances, renal impairment, or hypersensitivity to sulfonamide-derived drugs. Regular monitoring of serum electrolytes, renal function, and blood pressure is recommended during therapy to prevent potential adverse effects such as hypokalemia, hyponatremia, and dehydration. Zytanix 5 should be used under medical supervision, with dosage adjustments based on clinical response and laboratory parameters to ensure safety and efficacy in the management of fluid retention and hypertension.